Patricia Karwan, NP
Adult Health · Wakefield, RINPI 1700883568
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $927 of the $1,178 with a category attached, or 78.7%. It is spread thinly across 18 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $710, more than ten times the $16 reported in 2021.
Across 38 payments — averaging $30.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$194
- Johnson & Johnson$173
- AstraZeneca$156
- GSK$145
- E.r. Squibb & Sons, L.L.C.$72
- ADC Therapeutics America, Inc.$60
- plus $377 from 12 others
What the payments were for
- Food & beverage$92779%
- Education$25021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $194 |
| Johnson & Johnson | 4 | $173 |
| AstraZeneca | 4 | $156 |
| GSK | 3 | $145 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| ADC Therapeutics America, Inc. | 2 | $60 |
| Merck | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Sobi, Inc | 1 | $36 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Bayer | 1 | $33 |
| Agios Pharmaceuticals, Inc. | 2 | $32 |
| Puma Biotechnology, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Bristol Myers Squibb | 1 | $26 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Gilead | 1 | $22 |
| Exelixis Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$111
How this compares
$1,178 in reported general payments places this provider in the 80th percentile of 65 adult health providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KisqaliRibociclib Succinate | 16 | $235,936 |
| Anastrozole | 52 | $1,111 |
| Tamoxifen Citrate | 39 | $1,014 |
| Megestrol Acetate | 17 | $710 |
| Letrozole | 28 | $522 |
| Prochlorperazine Maleate | 44 | $485 |
| Oxycodone Hcl | 28 | $385 |
| Dexamethasone | 17 | $251 |
| Gabapentin | 13 | $148 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $144 |
| Tramadol Hcl | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Other adult health in Wakefield
- Diane McKeeffWakefield$1K
- Jacqueline AlbrikesJohnston$14K
- Elizabeth McGrathBarrington$7K
- Kathleen FranchinaWarwick$5K
- Deirdre CoutureCranston$5K
- Janine ZuromskiEast Greenwich$5K
- Christine UyProvidence$4K
- Kathleen RasslerEast Greenwich$3K
- Lindsay LeddyWarwick$3K
- Phina MayuProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.